Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 107-112

  Deng, Shishan ^a   Wang, Jianguo ^a   Hou, Lingmi ^a   Li, Jinsui ^a   Chen, Guo ^a   Jing, Baoqian ^a   Zhang, Xiaoming ^a   Yang, Zhengwei ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Annexins; Breast cancer; Immunohistochemical staining; Laryngeal carcinoma; Overexpression; Pancreatic cancer; Proteomics

Indexed keywords

LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; LIPOCORTIN 5;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MALE; MOLECULARLY TARGETED THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEOMICS;

EID: 84869002321     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.959     Document Type: Article

References (23)

1. Chuthapisith S, Bean BE, Cowley G, et al: Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 45: 1274-1281, 2009.
2. Lin LL, Chen CN, Lin WC, et al: Annexin A4: a novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin Appl 2: 619-634, 2008.
3. Qi YJ, Wang LD, Jiao XY, et al: Dysregulation of annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province. Ai Zheng 26: 730-736, 2007 (In Chinese).
4. Ji NY, Park MY, Kang YH, et al: Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med 24: 765-771, 2009.
5. Rodrigo JP, Garcia-Pedrero JM, Fernandez MP, Morgan RO, Suárez C and Herrero A: Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol 9: 483-587, 2005.
6. Kim JK, Kim PJ, Jung KH, et al: Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression. Oncol Rep 24: 607-612, 2010.
7. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
8. Deng S, Zhou H, Xiong R, et al: Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. Breast Cancer Res Treat 104: 21-30, 2007.
9. Marzook H, Li DQ, Nair VS, et al: Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A. J Biol Chem 287: 5615-5626, 2012.
10. Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM and Patel PS: Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem 25: 250-259, 2010.
11. Rohwer N, Lobitz S, Daskalow K, et al: HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer 100: 772-781, 2009.
12. Yi S, Guangqi H and Guoli H: The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chin Med Sci J 18: 87-92, 2003.
13. Wang KL, Wu TT, Resetkova E, et al: Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12: 4598-4604, 2006.
14. Sharma M, Ownbey RT and Sharma MC: Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 88: 278-286, 2010.
15. Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK and Tyson DR: Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Int J Cancer 124: 68-74, 2009.
16. Moon HS, Lee YS and Chung HW: The annexin II expression in invasive cervical cancer. Korean J Gynecol Oncol 18: 8-16, 2007.
17. Huang Y, Jin Y, Yan CH, et al: Involvement of annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem 309: 117-123, 2008.
18. Chan CM, Wong SC, Lam MY, et al: Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. Arch Pathol Lab Med 2132: 675-683, 2008.
19. Duncan R, Carpenter B, Main LC, Telfer C and Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433, 2008.
20. Xue G, Hao LQ, Ding FX, et al: Expression of annexin A5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. J Clin Gastroenterol 43: 831-837, 2009.
21. Zhang J, Guo B, Zhang Y, Cao J and Chen T: Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. Saudi Med J 31: 374-381, 2010.
22. Alves VA, Nonogaki S, Cury PM, et al: Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology 53: 715-727, 2008.
23. Sitek B, Sipos B, Alkatout I, et al: Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res 8: 1647-1656, 2009.